Abstract:ID 91703 Poster Board 477 Cancer patients commonly experience neuropathic pain caused by off-target effects of their chemotherapeutic treatments known as chemotherapy-induced peripheral neuropathy (CIPN), or by tumor metastasis to bone known as cancer-induced bone pain (CIBP). There are currently no treatments for either of these cancer-related neuropathies and current clinical regimens focus on symptom management. Current treatments have limited therapeutic windows due to negative side effects associated with utilized therapeutics that include opioids, anti-depressants, and gabapentinoids. A recently synthesized allosteric modulator of the g-protein activated inwardly rectifying potassium channels (GIRK) 1 and 2, known as GAT-1508, may be able to provide effective anti-allodynic effects with an improved therapeutic window. Utilizing CIPN and CIBP preclinical models, we assessed whether GAT-1508 would attenuate cancer-related mechanical allodynia. The CIPN model was induced in male and female C57BL/6 mice via a dosing cycle (8 mg/kg ip, given every other day, 32 mg/kg cumulative) of paclitaxel, a chemotherapeutic agent. The CIBP neuropathic pain model was induced in male and female C3H/HeJ mice, a mouse strain that is syngeneic to the murine fibrosarcoma cell line, NCTC-2472. Following implantation of NCTC-2472 fibrosarcoma cells into the calcaneus bone, mice exhibited mechanical allodynia associated with bone tumor metastasis. Vehicle injection served as a control and the von Frey assay was utilized to assess mechanical allodynia in both models. GAT-1508 (17.8–100 mg/kg, ip) dose-relatedly attenuated CIPN-induced mechanical allodynia (F (1.42, 21.36) = 485.6, p < 0.0001). Similarly, GAT-1508 dose-relatedly attenuated CIBP-induced mechanical allodynia (F 1.3, 9.1) = 22.64, p < 0.001). Additionally, at the highest dose tested (100 mg/kg, i.p.), GAT-1508 did not alter locomotor behavior, including distance ( p = 0.71) and speed ( p = 0.77). GAT-1508 dose-relatedly attenuated mechanical allodynia in both models. Given that no locomotor effects were observed, GAT-1508 may provide therapeutic effects with an improved therapeutic window and limited side-effects. Ultimately, these findings support further development and study of GIRK channel modulation for potential neuropathic pain therapeutics.

Amitriptyline inhibits EAG1 Channels and decreases the Proliferation and Migration of Cancer Cells

The Antidepressant Drug Amitriptyline Affects Human SH-SY5Y Neuroblastoma Cell Proliferation and Modulates Autophagy

Molecular mechanism of EAG1 channel inhibition by imipramine binding to the PAS domain

The Inhibitory Effect of 3Β-Hydroxy-12-oleanen-27-oic Acid on Growth and Motility of Human Hepatoma HepG2 Cells Through JNK and Akt Signaling Pathway

Inhibition of Acid Sphingomyelinase‐mediated Autophagic Flux Contributes to Amitriptyline‐induced Perturbation of Tube Formation in Murine Endothelial Cells

The tricyclic antidepressant amitriptyline inhibits D-cyclin transactivation and induces myeloma cell apoptosis by inhibiting histone deacetylases: in vitro and in silico evidence.

Chlorpromazine inhibits EAG1 channels by altering the coupling between the PAS, CNBH and pore domains

Assessment of an Allosteric Modulator of GIRK 1/2 in Preclinical Models of Cancer-Related Neuropathies to Alleviate Associated Mechanical Allodynia

Potentiation of Amitriptyline Anti-Hyperalgesic-Like Action By Astroglial Connexin 43 Inhibition in Neuropathic Rats

Tricyclic antidepressant amitriptyline inhibits 5-hydroxytryptamine 3 receptor currents in NCB-20 cells

Zc88, A Novel 4-Amino Piperidine Analog, Inhibits The Growth Of Neuroblastoma Cells Through Blocking Herg Potassium Channel

AMPK activation attenuates cancer-induced bone pain by reducing mitochondrial dysfunction-mediated neuroinflammation

A Multi-Targeting Natural Product, Aiphanol, Inhibits Tumor Growth and Metastasis.

Amitriptyline Protects Against Lidocaine-induced Neurotoxicity in SH-SY5Y Cells via Inhibition of BDNF-mediated Autophagy

Stimulation of electroporation-induced inward currents in glioblastoma cell lines by the heat shock protein inhibitor AUY922

2-Aminoethyl Dihydrogen Phosphate (2-AEH2P) Associated with Cell Metabolism-Modulating Drugs Presents a Synergistic and Pro-Apoptotic Effect in an In Vitro Model of the Ascitic Ehrlich Tumor

Abstract 5448: The tricyclic anti-depressant amitriptyline inhibits D-cyclin transactivation and induces myeloma cell apoptosis by inhibiting histone deacetylases

Glutamatergic Neurons in the Amygdala Are Involved in Paclitaxel-Induced Pain and Anxiety

Activation of Adenosine Monophosphate–activated Protein Kinase Suppresses Neuroinflammation and Ameliorates Bone Cancer Pain

Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogons

Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis